The Relationship between SLC22A16 Gene Polymorphism and Hematological Toxicity in Breast Cancer Patients Receiving Doxorubicin-Based Chemotherapy

Authors

  • SRI MELINDA KABAN Universitas Sumatera Utara
  • Siti Syarifah Universitas Sumatera Utara
  • Yunita Sari Pane Universitas Sumatera Utara
  • Tri Widyawati Universitas Sumatera Utara

DOI:

https://doi.org/10.32734/jetromi.v7i1.18520

Keywords:

SLC22A16, Polymorhism, Breast Cancer, Doxorubicine,Hematology Toxicity

Abstract

ABSTRACT

Background Drug transporter polymorphisms are widely associated with the risk of toxicity in many chemotherapy drugs in cancer. This paper aims to assess the relationship of polymorphisms of this transporter, namely SLC22A16, which are associated with side effects of Doxorubicin-based chemotherapy drugs, namely hematological toxicity (anemia, neutropenia, leukopenia and thrombocytopenia) in breast cancer patients.

Method This cross-sectional study will be conducted by testing polymorphism using the ARMS PCR method, which will assess the distribution of AA, AG, and GG genotypes.

Result  Most patient ages are under 50 years (55%), with overweight BMI (41,7%) and Batak ethnicity (43,3%). There is no relationship between SLC22A16 Gene Polymorphism and Hematological Toxicity in Breast Cancer Patients Receiving Doxorubicin-Based Chemotherapy

Downloads

Download data is not yet available.

Downloads

Published

2025-02-12

Issue

Vol. 7 No. 1 (2025): Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI)

Section

Articles

License

Copyright (c) 2025 Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Journal of Endocrinology, Tropical Medicine and Infectious Diseases (JETROMI).

Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, will be allowed only with a written permission from Journal of Endocrinology, Tropical Medicine and Infectious Diseases (JETROMI).